Publications and health information

Burgers WA, Riou C, Mlotshwa M, Maenetje P, de Assis Rosa D, Brenchley J, Mlisana K, Douek DC, Koup R, Roederer M, de Bruyn G, Abdool Karim S, Williamson C, Gray CM and the Caprisa 002 Acute Infection Study Team. Association of HIV-Specific and Total CD8+ T Memory Phenotypes in Subtype C HIV-1 Infection with Viral Set Point. The Journal of Immunology. 2009. 182:4751-4761.

Cornell M, Myer L, Kaplan R, Bekker LG, Wood R. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Tropical Medicine & International Health. July 09.14(7):722-731.

Cornell M, Technau K, Fairall L, Wood R, Moultrie H, van Cutsem G, Giddy J, Mohapi L, Eley B, MacPhail P, Prozesky H, Rabie H, Davies MA, Maxwell N, Buolle A, for the International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration. Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: The IeDEA Southern Africa collaboration. South African Medical Journal. September 2009. 99(9):653-660.

De Bruyn G, Martinson NA, Nkala BD, Tshabangu N, Shilaluke G, Kublin J, Corey L, Gray GE. Uptake of Male Circumcision in an HIV Vaccine Efficacy Trial. Journal of Acquired Immune Deficiency Syndrome. (Letter) 51:1:108-110.

DeLuca A, Chaisson RE, Martinson NA. Intensified Case Finding for Tuberculosis in Prevention of Mother-to-Child Transmission Programs: A Simple and Potentially Vital Addition for Maternal and Child Health. Journal of Acquired Immune Deficiency Syndrome. 50:2:196-199 1 Feb 2009.

Forrest JI, Kaida A, Dietrich J, Miller CL, Hogg RS, Gray G. Perceptions of HIV and Fertility Among Adolescents in Soweto, South Africa: Stigma and Social Barriers Continue to Hinder Progress. AIDS and Behaviour 2009.

Gray GE, McIntyre J. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1. AIDS. 2009.

Gray GE. Adolescent HIV – Cause for Concern in Southern Africa. PLoS Medicine 7(2) Feb 09.


Mesesan K, Van Niekerk RM, Niccolai LM, Mlungwana ON, Holdsworth IM, Bogochi M, McIntyre JA, Gray GE, Vardas E. Sexual Risk Behavior of the First Cohort Undergoing Screening for Phase I/II HIV Vaccine Trials in South Africa. International Journal of STD & AIDS. Feb 09 20(2)95-101.

Golub J, Chaisson R, Martinson N. Additive effects of isoniazid preventive therapy and HAART. AIDS. 23(11):146-147 17 July 2009.

Golub JE, Pronyk P, Mohapi L, Tshabangu N, Moshabela M, Struthers H, Gray GE, McIntyre JA, Chaisson RE, Martinson NA. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: A prospective cohort. AIDS. 23:5;631-636. 13 March 2009.

Hirt D, Urien S, Ekouévi D, Rey E, Arrivé E, Blanche S, Amani-Bosse C, Nerrienet E, Gray G, Kone M, Leang S, McIntyre J, Dabis F, Tréluyer JM. Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109). Clinical Pharmacology & Therapeutics. Feb 2009 85(2):182-9.

Kaida A, Bangsberg DR, Gray G, Hogg RS, King R, Miller CL. Editorial: Introduction to the Supplement on HIV, HAART, and Fertility in sub-Saharan Africa. AIDS and Behaviour. 12 May 2009 13:s1-S4.

Laher F, Todd CS, Stibich MA, Phofa R, Behane X, Mohapi L, Gray G. A Qualitative Assessment of Decisions Affecting Contraceptive Utilization and Fertility Intentions Among HIV-Positive Women in Soweto, South Africa. AIDS and Behaviour 2009.

Lazarus R, Struthers H, Violari A. Hopes, fears, knowledge and misunderstandings: responses of HIV-positive mothers to early knowledge of the status of their baby. AIDS Care. March 2009.

Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret A, Baeten J, Bukusi EA, Cohen CR, Katabira E, Ronald A, Kiarie J, Farquhar C, Stewart GJ, Makhema J, Essex M, Were E, Fife K, de Bruyn G, Gray G, McIntyre J, Manongi R, Kapiga S, Coetzee D, Allen S, Inambao M, Kayitenkore K, Karita E, Kanweka W, Delany S, Rees H, Vwalika B, Coombs RW, Morrow R, Whittington W, Corey L, Wald A, Celum C for the Partners HSV-2/HIV-1 Transmission Study Team. Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study. PLoS ONE. 2009 April 4(4)e5272.

MacCarthy S, Kaida A, Laher F, Farlane L, Nduna M. Responding to Her Question: A review of the influence of pregnancy on HIV disease progression in the context of expanded access to HAART in sub-Saharan Africa. AIDS and Behaviour 2009.

MacPherson P, Moshabela M, Martinson N, Pronyk P. Mortality and loss to follow-up among HAART initiators in rural South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. Jun 2009:103:588-593.

Morris L, Williamson C, Mlisana K, Gray G. Where are we going with HIV vaccines? South African Journal of Sciences. 105 May/June 2009.

Martinson N. Tuberculosis in South Africa: Pandora’s Box? South African Centre for Epidemiological Modeling and Analysis. 3 Sep 2009.

Martinson N, Mohapi L, Bakos D, Gray GE, McIntyre JA, Holmes CB. Costs of Providing Care for HIV-Infected Adults in an Urban HIV Clinic in Soweto, South Africa. Journal of Acquired Immune Deficiency Syndrome.. 50:3:327-330. 1 March 2009.

Martinson NA, Morris L, Johnson J, Gray GE, Pillay V, Ledwaba J, Dhlamini P, Cohen S, Puren A, Steyn J, Heneine W, McIntyre JA. Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance. AIDS. 27;7:809-816 April 27, 2009.

Martinson N, Moultrie H, Van Niekerk R, Barry G, Coovadia A, Cotton M, Violari A, Gray GE, Chaisson RE, McIntyre JA, Meyers T. HAART and risk of tuberculosis in HIV-infected South African children: A multi-site retrospective cohort. International Journal of Tuberculosis and Lung Disease. 2009 Jul;13(7):862.

McIntyre JA, Hopley M, Moodley D, Eklund M, Gray GE, Hall DB, Robinson P, Mayers D, Martinson NA. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child hiv transmission: a randomized clinical trial. PLoS Medicine. October 2009 6(10).

Mnyani CN, McIntyre JA. Preventing mother-to-child transmission of HIV. BJOG: An International Journal of Obstetrics and Gynaecology. 2009;116. Supplement 1:71-76.

Mnyani C. Interventions for preventing late postnatal mother-to-child transmission of HIV. WHO Reproductive Health Library; 2009. [Article not available online].

Montgomery ET, Blanchard K, Cheng H, Chipato T, de Bruyn G, Ramjee G, Padian N, van der Straten and the MIRA team. Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa. The European Journal of Contraception & Reproductive Health Care. 2009 December 2009; 14:6:410-419.

Opuni M, Bishai D, Gray GE, McIntyre JA, Martinson NA. Preferences for characteristics of antiretroviral therapy provision in Johannesburg, South Africa: Results of a conjoint analysis. AIDS and Behaviour. 16 June.

Paximadis M, Mohanlal N, Gray GE, Kuhn L, Tiemessen CT. Identification of new variants within the two functional genes CCL3 and CCL3L encoding the CCL3 (MIP-1alpha) chemokine: implications for HIV-1 infection. International Journal of Immunogenetics. 36(1):21-32. February 2009.

Sawe FK, McIntyre JA. Monitoring HIV antiretroviral therapy in resource limited settings: time to avoid costly outcomes. Clinical Infectious Diseases. 1 Aug 2009. 49(3):463-465.

Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting. Journal of Acquired Immune Deficiency Syndrome. 2009 October 1; 52(2).

Shalekoff S, Meddows-Taylor S, Gray GE, Sherman GG, Coovadia AH, Kuhn L, Tiemessen CT. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS 27;7:789-798 April 27, 2009.

Shalekoff S, Meddows-Taylor S, Schramm DB, Gray G, Sherman G, Coovadia A, Kuhn L, Tiemessen CT. Single-Dose Nevirapine Exposure Affects T Cell Response and Cytokine Levels in HIV Type 1-Infected Women. AIDS Research and Human Retroviruses. 2009; 25(10).

Tiemessen CT, Shalekoff S, Meddows-Taylor S, Schramm DB, Papathanasopoulos MA, Gray GE, Sherman GG, Coovadia AH, Kuhn L. Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. Journal of Immunology. 2009 May 15;182(10):5914-8.

Tsai A, Chopra M, Pronyk P, Martinson N. Socioeconomic Disparities in Access to HIV/AIDS Treatment Programs in Resource-Limited Settings. AIDS Care. Jan 2009 21(1):59-63.

Van der Straten A, Shiboski S, Montgomery ET, Moore J, de Bruyn G, Ramjee G, Chidanyika A, Kacanek D, Padian N and the MIRA team. Patterns and Predictors of Adherence to Diaphragm Use in a Phase lll Trial in Sub-Saharan Africa: A Trajectory Analysis. Journal of Acquired Immune Deficiency Syndrome. 50;4:419-426. 1 April 2009.

Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; for the CEPAC-International Investigators. When to start antiretroviral therapy in resource-limited settings. Annals of Internal Medicine. 20 July 2009. 151:157-166.

Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, Siliciano JD, Quinn TC, Siliciano RF. Identification of Nevirapine-Resistant HIV-1 in the Latent Reservoir after Single Dose Nevirapine to Prevent Mother-to-Child Transmission of HIV-1. Journal of Investigative Dermatology. 2009 May 1. 199:1301-1309.

Wong LH, Van Rooyen H, Modiba P, Richter L, Gray G, McIntyre JA, Dunkel Schetter C, Coates T. Test and tell: Correlates and Consequences of Testing and Disclosure of HIV Status in South Africa (HPTN 043 Project Accept). Journal of Acquired Immune Deficiency Syndrome. 1 Feb 2009. 50:2:215-222.